An interventional study of Transcranial magnetic stimulation (Hf rTMS) in Dyslexia, Specific Learning Disability and Transcranial Magnetic Stimulation, sponsored by All India Institute of Medical Sciences, New Delhi. Recruiting at 1 site in India. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-06-28.
Sponsored by All India Institute of Medical Sciences, New Delhi · Not applicable, Interventional, and Treatment
Dyslexia is the most common neurobehavioral disorder affecting children, with prevalence rates ranging from 17.5% to 21%. Studies have shown incomplete response to remediation and behavioural therapies in children with dyslexia. Evidence from neuroimaging studies as well as neuromodulation studies supporting a neurobiological basis of dyslexia is extensive according to which under-activation and poor connectivity in the underlying pathways for language and reading is the primary pathophysiology underlying reading difficulties. Evidence from studies on neuromodulation have shown that by combining remedial intervention with neuromodulation there is a synergistic effect through the mechanism of long term potentiation. In view of the above mentioned our study aims to investigate the role of Hf rTMS as an adjunct to AI enabled remedial intervention in children with dyslexia in improving their reading abilities.
AI enabled remedial intervention -
rTMS procedure
Follow up
Control - For controls investigators will be using the retrospective data of children with dyslexia who received AI enabled remedial intervention alone (for 6 weeks) as a part of a previous study by Dr Sayoni under the guidance of Prof Sheffali Gulati as Chief guide.
•Assessment Tools
127 studies on the registry are indexed under Dyslexia; 27 are open to participants now.
This study's planned enrollment of 60 is below the median of 71 across 106 interventional studies indexed under Dyslexia.
Browse Dyslexia studies →All India Institute of Medical Sciences, New Delhi is the lead sponsor of 143 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children who have given consent for the study and are fulfilling the inclusion and exclusion criteria will be enrolled and given Transcranial magnetic stimulation (TMS) as per protocol as described below over 12 week along with AI based remedial intervention. TMS protocol - 5 Hz High frequency rTMS, at 100% RMT, 60 pulses per train, total 10 trains , gap between 2 consecutive trains of 30 sec, at left IPL and left STG localised using 10-20 EEG based system at P3 and P5 respectively , using figure of 8 coil 1st cycle of 10 sessions over 10 consecutive days, 2nd cycle of 5 sessions over 5 consecutive days , 3rd cycle for 5 sessions over 5 consecutive days ; gap of 6 weeks between 2 consecutive cycles Total 3 cycles per patient
Device: Transcranial magnetic stimulation (Hf rTMS)
TMS protocol - 5 Hz High frequency rTMS, at 100% RMT, 60 pulses per train, total 10 trains , gap between 2 consecutive trains of 30 sec, at left IPL and left STG localised using 10-20 EEG based system at P3 and P5 respectively , using figure of 8 coil 1st cycle of 10 sessions over 10 consecutive days, 2nd cycle of 5 sessions over 5 consecutive days , 3rd cycle for 5 sessions over 5 consecutive days ; gap of 6 weeks between 2 consecutive cycles Total 3 cycles per patient
Also known as: AI based remedial intervention
Improvement in reading abilities of the participants as assessed by CTOPP-2 scores at 6 and 12 weeks from baseline.
Difference in mean of CTOPP-2 scores at 6 and 12 weeks from baseline. CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition -tool has been explained in the study description section above.
Time frame: From baseline to 6 and 12 weeks
Improvement in reading abilities of the participants as assessed by GLAD scores at 6 and 12 weeks from baseline.
Difference in mean of GLAD scores at 6 and 12 weeks from baseline. GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above.
Time frame: From baseline to 6 and 12 weeks
Improvement in reading abilities of the participants as assessed by WRAT-5 scores at 6 and 12 weeks from baseline.
Difference in mean of WRAT5 scores at 6 and 12 weeks from baseline. WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above.
Time frame: From baseline to 6 and 12 weeks
Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by CTOPP-2 scores at 6 weeks as compared to controls (who received only AI based remedial intervention).
Difference in mean of change in CTOPP-2 scores at 6 weeks between the intervention group and the retrospective data of controls CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition The tool has been explained in the study description section above.
Time frame: From baseline to 6 weeks
Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by GLAD scores at 6 weeks as compared to controls (who received only AI based remedial intervention).
Difference in mean of change in GLAD scores at 6 weeks between the intervention group and the retrospective data of controls GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above.
Time frame: From baseline to 6 weeks
Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by WRAT5 scores at 6 weeks as compared to controls (who received only AI based remedial intervention).
Difference in mean of change in WRAT5 scores at 6 weeks between the intervention group and the retrospective data of controls WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above.
Time frame: From baseline to 6 weeks
To compare the domain wise change CTOPP-2 scores of participants pre and post intervention
Difference in mean of Domain wise CTOPP2 score at 6 and 12 weeks from baseline CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition - details of the tools have been described in the study description section above.
Time frame: From baseline to 6 and 12 weeks
To compare the domain wise change WRAT-5 scores of participants pre and post intervention
Difference in mean of Domain wise WRAT-5 score at 6 and 12 weeks from baseline WRAT-5 - Wide Range achievement test, 5th edition - details of the tools have been described in the study description section above
Time frame: From baseline to 6 and 12 weeks
To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by WRAT5 scores
Difference in mean of WRAT-5 scores at 24 weeks from 12 weeks and from baseline WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above.
Time frame: From baseline to 24 weeks from 12 weeks and
To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by GLAD scores
Difference in mean of GLAD scores at 24 weeks from 12 weeks and from baseline GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above.
Time frame: From baseline to 24 weeks from 12 weeks and
To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by CTOPP-2 scores
Difference in mean of CTOPP-2 scores at 24 weeks from 12 weeks and from baseline CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition The tool has been explained in the study description section above.
Time frame: From baseline to 24 weeks from 12 weeks and
To evaluate the cortical excitability parameter - RMT pre and post intervention
Mean change in RMT from baseline at 6 weeks, 12 weeks and 24 weeks into the study RMT - Resting Motor Threshold
Time frame: at 6 weeks, 12 weeks and 24 weeks into the study
To evaluate the resting state functional networks and brain activation profile during phonological tasks using functional MRI in dyslexic children pre and post intervention
Differences in functional connectivity and Difference in activation scores of ROI (region of Interest) during the phonological tasks on f MRI from baseline at 12 weeks (at end of intervention)
Time frame: from baseline at 12 weeks (at end of intervention)
To describe adverse events noted during Hf rTMS
AE= Positive increase in any of the ROS (review of systems) criteria compared to pre therapy No of patients who have had atleast 1 AE AE rate: ratio of sessions with adverse events divided by total sessions
Time frame: 12 weeks
To describe subjective improvement as assessed by parents and teachers of children with dyslexia
Subjective Improvement as assessed by the parent and teacher on a 7 point Likert scale
Time frame: at 6 weeks, 12 weeks and 24 weeks from baseline
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2023 (actual). Primary completion is estimated for Dec 2025, 35 months after the start.
Of 62 non-industry interventional studies with no phase under Dyslexia, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 57. This study's planned 35 months is above that.
Counting every sponsor, half of 69 studies reached it within 24 months; a quarter within 9 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
All India Institute of Medical Sciences, New Delhi →